Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mia Wadelius

Showing results (41-50 of 92) with videos related to

Pageof 10
Sort By:
The Annals of Pharmacotherapy|November 28, 2016
Comparison of Clinical Factors Between Patients With Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema and CoughPär Hallberg, Julia Nagy, Malgorzata Karawajczyk, et al.
Blood|June 25, 2008
The largest prospective warfarin-treated cohort supports genetic forecastingMia Wadelius, Leslie Y Chen, Jonatan D Lindh, et al.
International Journal of Otolaryngology|April 25, 2018
Corrigendum to "Assessment of 105 Patients with Angiotensin Converting Enzyme-Inhibitor Induced Angioedema"Eva Rye Rasmussen, Christian von Buchwald, Mia Wadelius, et al.
Pharmacogenomics|January 14, 2017
Genetic variants associated with angiotensin-converting enzyme inhibitor-induced cough: a genome-wide association study in a Swedish populationPär Hallberg, Matilda Persson, Tomas Axelsson, et al.
Frontiers in Genetics|September 25, 2020
High-Throughput Sequencing to Investigate Associations Between HLA Genes and Metamizole-Induced AgranulocytosisAnca Liliana Cismaru, Livia Grimm, Deborah Rudin, et al.
Pharmacogenetics and Genomics|December 14, 2011
Association of the GGCX (CAA)16/17 repeat polymorphism with higher warfarin dose requirements in African AmericansLarisa H Cavallari, Minoli Perera, Mia Wadelius, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 16, 2026
HLA-B*44 Alleles and HLA-DQA1*03:01 as Genetic Risk Factors for Drug-Induced Liver Injury due to FluoroquinolonesPaola Nicoletti, M Isabel Lucena, Raul J Andrade, et al.
Ebiomedicine|February 4, 2019
Pandemrix-induced narcolepsy is associated with genes related to immunity and neuronal survivalPär Hallberg, Hans Smedje, Niclas Eriksson, et al.
Plos Genetics|March 21, 2009
A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin doseFumihiko Takeuchi, Ralph McGinnis, Stephane Bourgeois, et al.
Pharmacogenomics|August 5, 2016
Genetic determinants of warfarin maintenance dose and time in therapeutic treatment range: a RE-LY genomics substudyNiclas Eriksson, Lars Wallentin, Lars Berglund, et al.
Pageof 10

Showing results (41-50 of 92) with videos related to

Sort By:
Pageof 10
The Annals of Pharmacotherapy|November 28, 2016
Comparison of Clinical Factors Between Patients With Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema and CoughPär Hallberg, Julia Nagy, Malgorzata Karawajczyk, et al.
Blood|June 25, 2008
The largest prospective warfarin-treated cohort supports genetic forecastingMia Wadelius, Leslie Y Chen, Jonatan D Lindh, et al.
International Journal of Otolaryngology|April 25, 2018
Corrigendum to "Assessment of 105 Patients with Angiotensin Converting Enzyme-Inhibitor Induced Angioedema"Eva Rye Rasmussen, Christian von Buchwald, Mia Wadelius, et al.
Pharmacogenomics|January 14, 2017
Genetic variants associated with angiotensin-converting enzyme inhibitor-induced cough: a genome-wide association study in a Swedish populationPär Hallberg, Matilda Persson, Tomas Axelsson, et al.
Frontiers in Genetics|September 25, 2020
High-Throughput Sequencing to Investigate Associations Between HLA Genes and Metamizole-Induced AgranulocytosisAnca Liliana Cismaru, Livia Grimm, Deborah Rudin, et al.
Pharmacogenetics and Genomics|December 14, 2011
Association of the GGCX (CAA)16/17 repeat polymorphism with higher warfarin dose requirements in African AmericansLarisa H Cavallari, Minoli Perera, Mia Wadelius, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 16, 2026
HLA-B*44 Alleles and HLA-DQA1*03:01 as Genetic Risk Factors for Drug-Induced Liver Injury due to FluoroquinolonesPaola Nicoletti, M Isabel Lucena, Raul J Andrade, et al.
Ebiomedicine|February 4, 2019
Pandemrix-induced narcolepsy is associated with genes related to immunity and neuronal survivalPär Hallberg, Hans Smedje, Niclas Eriksson, et al.
Plos Genetics|March 21, 2009
A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin doseFumihiko Takeuchi, Ralph McGinnis, Stephane Bourgeois, et al.
Pharmacogenomics|August 5, 2016
Genetic determinants of warfarin maintenance dose and time in therapeutic treatment range: a RE-LY genomics substudyNiclas Eriksson, Lars Wallentin, Lars Berglund, et al.
Pageof 10